The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.

Source:http://linkedlifedata.com/resource/pubmed/id/17287504

J. Neurosci. 2007 Feb 7 27 6 1297-307

Download in:

View as

General Info

PMID
17287504